Standard Biotools (LAB) Net Margin Growth (1y) (2011 - 2026)
Standard Biotools (LAB) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | -860.00 |
| 2 | Stryker | 126.18 Bn | 122.71 Bn | 4.50 Bn | 469.00 |
| 3 | Medtronic | 118.63 Bn | 109.41 Bn | 6.41 Bn | 94.00 |
| 4 | Boston Scientific | 72.75 Bn | 72.21 Bn | 3.85 Bn | 92.00 |
| 5 | Edwards Lifesciences | 52.10 Bn | 47.85 Bn | 1.35 Bn | -777.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 350.00 |
| 7 | GE HealthCare Technologies | 33.68 Bn | 31.57 Bn | 2.18 Bn | 85.00 |
| 8 | Koninklijke Philips | 26.32 Bn | 23.00 Bn | 4.55 Bn | -81.00 |
| 9 | Steris | 23.10 Bn | 22.62 Bn | 684.20 Mn | 67.00 |
| 10 | Standard Biotools | 251.69 Mn | -225.03 Mn | 10.54 Mn | 2,060.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12,772.00 |
| Mar 31, 2026 | 68,324.00 |
| Dec 31, 2025 | -6,511.00 |
| Sep 30, 2025 | -7,817.00 |
| Jun 30, 2025 | 3,191.00 |
| Mar 31, 2025 | 5,738.00 |
| Dec 31, 2024 | 588.00 |
| Sep 30, 2024 | -1,627.00 |
| Jun 30, 2024 | -5,154.00 |
| Mar 31, 2024 | -350.00 |
| Dec 31, 2023 | -51,684.00 |
| Sep 30, 2023 | 3,177.00 |
| Jun 30, 2023 | 27,687.00 |
| Mar 31, 2023 | 22,078.00 |
| Sep 30, 2022 | -6,078.00 |
| Jun 30, 2022 | -28,212.00 |
| Mar 31, 2022 | -23,053.00 |
| Sep 30, 2021 | -3,881.00 |
| Jun 30, 2021 | -639.00 |
| Mar 31, 2021 | 49.00 |